Atria Investments LLC Gsk PLC Transaction History

Atria Investments LLC

$7.56 Billion
Q3 2024

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 11, 2022	SELL	$42.05 - $47.77 $421,256 - $478,559	-10,018 Reduced 29.09%	24,418 $1.06 Million
Q1 2022 May 02, 2022	BUY	$40.23 - $47.74 $229,713 - $272,595	5,710 Added 19.88%	34,436 $1.5 Million
Q4 2021 Feb 04, 2022	BUY	$38.88 - $45.31 $1.12 Million - $1.3 Million	28,726 New	28,726 $1.27 Million
Q4 2020 Feb 12, 2021	SELL	$34.07 - $39.94 $1.18 Million - $1.38 Million	-34,676 Closed	0 $0
Q3 2020 Nov 05, 2020	SELL	$38.11 - $42.99 $280,146 - $316,019	-7,351 Reduced 17.49%	34,676 $1.31 Million
Q2 2020 Sep 22, 2020	BUY	$37.87 - $43.58 $321,970 - $370,517	8,502 Added 25.36%	42,027 $1.71 Million
Q1 2020 May 15, 2020	SELL	$32.47 - $48.83 $199,170 - $299,523	-6,134 Reduced 15.47%	33,525 $1.27 Million
Q4 2019 Feb 11, 2020	BUY	$42.0 - $48.25 $1.67 Million - $1.91 Million	39,659 New	39,659 $1.86 Million
Q2 2019 Aug 09, 2019	SELL	$39.4 - $42.7 $205,549 - $222,765	-5,217 Closed	0 $0
Q1 2019 May 15, 2019	SELL	$38.57 - $42.69 $89,405 - $98,955	-2,318 Reduced 30.76%	5,217 $218,000
Q4 2018 Feb 12, 2019	SELL	$37.8 - $42.69 $160,574 - $181,347	-4,248 Reduced 36.05%	7,535 $288,000
Q3 2018 Oct 09, 2018	BUY	$39.75 - $42.69 $38,517 - $41,366	969 Added 8.96%	11,783 $473,000
Q2 2018 Jul 13, 2018	SELL	$39.61 - $42.76 $249,701 - $269,559	-6,304 Reduced 36.83%	10,814 $436,000
Q1 2018 Apr 30, 2018	BUY	$36.18 - $40.15 $155,139 - $172,163	4,288 Added 33.42%	17,118 $669,000
Q4 2017 Jan 16, 2018	BUY	$35.34 - $41.9 $66,227 - $78,520	1,874 Added 17.1%	12,830 $455,000
Q3 2017 Oct 12, 2017	BUY	$39.44 - $41.55 $432,104 - $455,221	10,956	10,956 $445,000

Others Institutions Holding GSK

# of Institutions

Shares Held

176K

Call Options Held

Put Options Held

View Full List

About GSK PLC

Ticker GSK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,033,689,984
Market Cap $69.3B
Description
GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceutic...

More about GSK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Atria Investments LLC, based on Form 13F filings with the SEC.

News

Stay updated on Atria Investments LLC with notifications on news.

Account